Whilst this is more a puff piece than ASX news, it does have some interesting insights & background information on a number of areas.
I'd never thought of Rhinoswab being used in conjunction with Telehealth, but it makes some sense. Especially after seeing the video of the rapid testing centre and how the workers could observe, without getting too close.
They also touch on pricing per swab US$1.00 to $1.20 and implies "NSW Health carried out its own comprehensive evaluation before placing the order". That too bodes well, for additional orders.
Assuming they can get further orders, the next challenge appears to be that of where to manufacture and how best to scale.
https://www.biotechdaily.com.au/media/Dr%20Boreham/RNO%20Aug%2020%202021.pdf
